Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Brudno, J. N., Lam, N., Vanasse, D., Shen, Y., Rose, J. J., Rossi, J., Xue, A., Bot, A., Scholler, N., Mikkilineni, L., Roschewski, M., Dean, R., Cachau, R., Youkharibache, P., Patel, R., Hansen, B., Stroncek, D. F., Rosenberg, S. A., Gress, R. E., Kochenderfer, J. N.  Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.  Nature Medicine.  2020; 26(2), 270-280.  doi: 10.1038/s41591-019-0737-3

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.